John Baker is the founder of IMU Biosciences. IMU Biosciences has raised $166M in total funding. Latest round: Series A. Based in London, United Kingdom.
John Baker is the CEO of IMU Biosciences, where he oversees the company's precision-medicine platform focused on decoding the immune system. He is identified on both his LinkedIn profile and the company's website as leading this mission in precision medicine and immune-system profiling.
Full founder directory · Investor directory · Company funding database · Fundraising library